These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30358274)

  • 41. Time course of depression-symptom improvement during treatment with duloxetine.
    Hirschfeld RM; Mallinckrodt C; Lee TC; Detke MJ
    Depress Anxiety; 2005; 21(4):170-7. PubMed ID: 16035056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
    Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
    Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative effectiveness in pain-related outcomes and health care utilizations between veterans with major depressive disorder treated with duloxetine and other antidepressants: a retrospective propensity score-matched comparison.
    Shi L; Liu J; Zhao Y
    Pain Pract; 2012 Jun; 12(5):374-81. PubMed ID: 21951787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duloxetine in the treatment of elderly people with major depressive disorder.
    Del Casale A; Girardi P; Brugnoli R; Sani G; Di Pietro S; Brugnoli C; Caccia F; Angeletti G; Serata D; Rapinesi C; Tatarelli R; Kotzalidis GD
    Riv Psichiatr; 2012; 47(6):479-88. PubMed ID: 23160108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duloxetine in adults with ADHD: a randomized, placebo-controlled pilot study.
    Bilodeau M; Simon T; Beauchamp MH; Lespérance P; Dubreucq S; Dorée JP; Tourjman SV
    J Atten Disord; 2014 Feb; 18(2):169-75. PubMed ID: 22582349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study on comparative efficacy and cost effectiveness of Pregabalin and Duloxetine used in diabetic neuropathic pain.
    Roy MK; Kuriakose AS; Varma SK; Jacob LA; Beegum NJ
    Diabetes Metab Syndr; 2017; 11(1):31-35. PubMed ID: 27484440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition.
    Freeman MP; Hirschberg AM; Wang B; Petrillo LF; Connors S; Regan S; Joffe H; Cohen LS
    Maturitas; 2013 Jun; 75(2):170-4. PubMed ID: 23602542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds.
    Fornaro M; Rocchi G; Escelsior A; Contini P; Martino M
    J Affect Disord; 2013 Mar; 145(3):300-7. PubMed ID: 22981313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder.
    Meighen KG
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):121-7. PubMed ID: 17343560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Restless legs syndrome associated with the combined use of duloxetine plus paroxetine.
    Nikolaou KN; Michopoulos I; Douzenis A; Papazahos C; Papageorgiou C; Gournellis R
    J Clin Psychopharmacol; 2015 Jun; 35(3):345-6. PubMed ID: 25815756
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.
    Wang J; Liu X; Mullins CD
    Curr Med Res Opin; 2011 Jul; 27(7):1303-13. PubMed ID: 21561393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Duloxetine for childhood depression with pain and dissociative symptoms.
    Desarkar P; Das A; Sinha VK
    Eur Child Adolesc Psychiatry; 2006 Dec; 15(8):496-9. PubMed ID: 16732464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression.
    Mikoteit T; Hemmeter U; Eckert A; Brand S; Bischof R; Delini-Stula A; Holsboer-Trachsler E; Beck J
    Neuropsychobiology; 2015; 72(1):16-28. PubMed ID: 26337518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression.
    Rosso G; Rigardetto S; Bogetto F; Maina G
    J Affect Disord; 2012 Jan; 136(1-2):172-176. PubMed ID: 21862138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of duloxetine for the treatment of chronic nonorganic orofacial pain.
    Nagashima W; Kimura H; Ito M; Tokura T; Arao M; Aleksic B; Yoshida K; Kurita K; Ozaki N
    Clin Neuropharmacol; 2012; 35(6):273-7. PubMed ID: 23123692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frontal regional homogeneity increased and temporal regional homogeneity decreased after remission of first-episode drug-naïve major depressive disorder with panic disorder patients under duloxetine therapy for 6 weeks.
    Lai CH; Wu YT
    J Affect Disord; 2012 Feb; 136(3):453-8. PubMed ID: 22137181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.
    Eckert L; Lançon C
    BMC Psychiatry; 2006 Jul; 6():30. PubMed ID: 16867188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Duloxetine and Subacute Pain after Knee Arthroplasty when Added to a Multimodal Analgesic Regimen: A Randomized, Placebo-controlled, Triple-blinded Trial.
    YaDeau JT; Brummett CM; Mayman DJ; Lin Y; Goytizolo EA; Padgett DE; Alexiades MM; Kahn RL; Jules-Elysee KM; Fields KG; Goon AK; Gadulov Y; Westrich G
    Anesthesiology; 2016 Sep; 125(3):561-72. PubMed ID: 27387351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.
    Mancini M; Perna G; Rossi A; Petralia A
    Expert Opin Pharmacother; 2010 May; 11(7):1167-81. PubMed ID: 20402555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.